2013
DOI: 10.1016/j.ddstr.2014.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Synaptic function as a preclinical and experimental medicine readout for disease-modifying therapy in Alzheimer's Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 75 publications
(76 reference statements)
0
3
0
Order By: Relevance
“…A main characteristic of AD is progressive synaptic transmission dysfunction that eventually leads to synaptic loss. 3 Thus, we investigated whether changes in synapse number were associated with different treatments. Synaptophysin is a presynaptic marker that is commonly used to determine the number of synapses.…”
Section: Long-term Combination Therapy With Ee and Mgt (Em) Preventmentioning
confidence: 99%
See 1 more Smart Citation
“…A main characteristic of AD is progressive synaptic transmission dysfunction that eventually leads to synaptic loss. 3 Thus, we investigated whether changes in synapse number were associated with different treatments. Synaptophysin is a presynaptic marker that is commonly used to determine the number of synapses.…”
Section: Long-term Combination Therapy With Ee and Mgt (Em) Preventmentioning
confidence: 99%
“…Hypotheses of pathology assume that AD is caused by deposition of extracellular amyloid‐β (Aβ) plaques or intracellular tangles composed of hyperphosphorylated microtubule‐associated protein, tau . Hippocampal neurons are primarily affected due to the vulnerability of pyramidal cell synapses at the early stage of AD, which eventually leads to functional impairment in cognition and memory …”
Section: Introductionmentioning
confidence: 99%
“…As such, BDNF participates in a variety of regulatory functions including ocular dominance during development, body weight regulation, emotion, and learning & memory (Chao, ; Huang and Reichardt, ; Bekinschtein et al, ). Because BDNF robustly regulates synaptogenesis and synaptic plasticity in adults and enhances neuronal survival, and that BDNF levels are significantly altered in several neurological diseases and disorders, synaptic repair mediated through BDNF‐TrkB mechanism has been proposed as a disease‐modifying strategy for drug discovery in neurological and psychiatric diseases (Lu et al, ).…”
Section: Introductionmentioning
confidence: 99%